RWD88 Real-World Economic Burden Pre- and Post-Progression to Metastatic Castration-Resistant Prostate Cancer (mCRPC) and after First-Line mCRPC Therapy Initiation
Jun 1, 2023, 00:00 AM
10.1016/j.jval.2023.03.2117
https://www.valueinhealthjournal.com/article/S1098-3015(23)02217-9/fulltext
Section Title :
Section Order :
11433
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02217-9&doi=10.1016/j.jval.2023.03.2117